cached image

Stanley Fahn, M.D. - Publications

Affiliations: 
Neurology Columbia University, New York, NY 
Area:
movement disorders, parkinson disease

201 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Williams L, Olszewska DA, Fearon C, Magennis B, McCarthy A, Rowland LP, Mayeux R, Page R, Fahn S, Beausang A, Lynch T. Ondine's Curse in Frontotemporal Dementia with Parkinsonism Linked to Chromosome 17 Caused by Variants. Movement Disorders Clinical Practice. 8: 954-958. PMID 34405105 DOI: 10.1002/mdc3.13265  0.717
2021 McRae C, Dunk M, Russell D, Ellgring H, Stern Y, Greene P, Fahn S, Henchcliffe C. Baseline Differences in Long-term Survivors and Nonsurvivors of the Colorado/Columbia Fetal Implant Trial. Journal of the International Neuropsychological Society : Jins. 1-8. PMID 34121635 DOI: 10.1017/S1355617721000680  0.377
2020 Yu E, Rudakou U, Krohn L, Mufti K, Ruskey JA, Asayesh F, Estiar MA, Spiegelman D, Surface M, Fahn S, Waters CH, Greenbaum L, Espay AJ, Dauvilliers Y, Dupré N, et al. Analysis of Heterozygous PRKN Variants and Copy-Number Variations in Parkinson's Disease. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 32970363 DOI: 10.1002/mds.28299  0.314
2019 Alcalay RN, Mallett V, Vanderperre B, Tavassoly O, Dauvilliers Y, Wu RYJ, Ruskey JA, Leblond CS, Ambalavanan A, Laurent SB, Spiegelman D, Dionne-Laporte A, Liong C, Levy OA, Fahn S, et al. SMPD1 mutations, activity, and α-synuclein accumulation in Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 30788890 DOI: 10.1002/Mds.27642  0.569
2018 Merchant SH, Vial F, Leodori G, Fahn S, Pullman SL, Hallett M. A novel exaggerated "spino-bulbo-spinal like" reflex of lower brainstem origin. Parkinsonism & Related Disorders. PMID 30316728 DOI: 10.1016/j.parkreldis.2018.10.007  0.556
2018 Shah H, Liong C, Levy OA, Waters C, Fahn S, Marder K, Kang UJ, Wolf P, Oliva P, Zhang K, Alcalay RN, Gutierrez J. Association of Low Lysosomal Enzymes Activity With Brain Arterial Dilatation: A Pilot Study. Stroke. PMID 29986930 DOI: 10.1161/Strokeaha.118.021964  0.381
2018 Ruskey JA, Greenbaum L, Roncière L, Alam A, Spiegelman D, Liong C, Levy OA, Waters C, Fahn S, Marder KS, Chung W, Yahalom G, Israeli-Korn S, Livneh V, Fay-Karmon T, et al. Increased yield of full GBA sequencing in Ashkenazi Jews with Parkinson's disease. European Journal of Medical Genetics. PMID 29842932 DOI: 10.1016/j.ejmg.2018.05.005  0.498
2018 Isaacson SH, Fahn S, Pahwa R, Tanner CM, Espay AJ, Trenkwalder C, Adler CH, Patni R, Johnson R. Parkinson's Patients with Dyskinesia Switched from Immediate Release Amantadine to Open-label ADS-5102. Movement Disorders Clinical Practice. 5: 183-190. PMID 29780852 DOI: 10.1002/mdc3.12595  0.343
2017 Martelli D, Luo L, Kang J, Kang UJ, Fahn S, Agrawal SK. Adaptation of Stability during Perturbed Walking in Parkinson's Disease. Scientific Reports. 7: 17875. PMID 29259237 DOI: 10.1038/S41598-017-18075-6  0.368
2017 Fahn S. The 200-year journey of Parkinson disease: Reflecting on the past and looking towards the future. Parkinsonism & Related Disorders. PMID 28784297 DOI: 10.1016/j.parkreldis.2017.07.020  0.386
2016 Alcalay RN, Levy OA, Wolf P, Oliva P, Zhang XK, Waters CH, Fahn S, Kang U, Liong C, Ford B, Mazzoni P, Kuo S, Johnson A, Xiong L, Rouleau GA, et al. SCARB2 variants and glucocerebrosidase activity in Parkinson's disease. Npj Parkinson's Disease. 2. PMID 27110593 DOI: 10.1038/Npjparkd.2016.4  0.633
2015 Sulzer D, Chaudhuri KR, Fahn S. Introducing a new journal on Parkinson's disease. Npj Parkinson's Disease. 1: 15006. PMID 28725680 DOI: 10.1038/npjparkd.2015.6  0.366
2015 Biglan KM, Shoulson I, Kieburtz K, Oakes D, Kayson E, Shinaman MA, Zhao H, Romer M, Young A, Hersch S, Penney J, Marder K, Paulsen J, Quaid K, ... ... Fahn S, et al. Clinical-Genetic Associations in the Prospective Huntington at Risk Observational Study (PHAROS): Implications for Clinical Trials. Jama Neurology. 1-9. PMID 26569098 DOI: 10.1001/Jamaneurol.2015.2736  0.406
2015 McCarthy A, Lonergan R, Olszewska DA, O'Dowd S, Cummins G, Magennis B, Fallon EM, Pender N, Huey ED, Cosentino S, O'Rourke K, Kelly BD, O'Connell M, Delon I, Farrell M, ... ... Fahn S, et al. Closing the tau loop: the missing tau mutation. Brain : a Journal of Neurology. PMID 26297556 DOI: 10.1093/Brain/Awv234  0.687
2015 Virmani T, Moskowitz CB, Vonsattel JP, Fahn S. Clinicopathological characteristics of freezing of gait in autopsy-confirmed Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 26234730 DOI: 10.1002/Mds.26346  0.736
2015 Robakis D, Fahn S. Defining the Role of the Monoamine Oxidase-B Inhibitors for Parkinson's Disease. Cns Drugs. 29: 433-41. PMID 26164425 DOI: 10.1007/s40263-015-0249-8  0.314
2015 Alcalay RN, Levy OA, Waters CC, Fahn S, Ford B, Kuo SH, Mazzoni P, Pauciulo MW, Nichols WC, Gan-Or Z, Rouleau GA, Chung WK, Wolf P, Oliva P, Keutzer J, et al. Glucocerebrosidase activity in Parkinson's disease with and without GBA mutations. Brain : a Journal of Neurology. PMID 26117366 DOI: 10.1093/Brain/Awv179  0.655
2015 Clark LN, Chan R, Cheng R, Liu X, Park N, Parmalee N, Kisselev S, Cortes E, Torres PA, Pastores GM, Vonsattel JP, Alcalay R, Marder K, Honig LL, Fahn S, et al. Gene-wise association of variants in four lysosomal storage disorder genes in neuropathologically confirmed Lewy body disease. Plos One. 10: e0125204. PMID 25933391 DOI: 10.1371/Journal.Pone.0125204  0.642
2015 Gan-Or Z, Alcalay RN, Bar-Shira A, Leblond CS, Postuma RB, Ben-Shachar S, Waters C, Johnson A, Levy O, Mirelman A, Gana-Weisz M, Dupré N, Montplaisir J, Giladi N, Fahn S, et al. Genetic markers of Restless Legs Syndrome in Parkinson disease. Parkinsonism & Related Disorders. 21: 582-5. PMID 25817513 DOI: 10.1016/J.Parkreldis.2015.03.010  0.39
2015 Kestenbaum M, Fahn S. Safety of IPX066 , an extended release carbidopa-levodopa formulation, for the treatment of Parkinson's disease. Expert Opinion On Drug Safety. 14: 761-7. PMID 25697185 DOI: 10.1517/14740338.2015.1015986  0.382
2015 Fahn S. The medical treatment of Parkinson disease from James Parkinson to George Cotzias. Movement Disorders : Official Journal of the Movement Disorder Society. 30: 4-18. PMID 25491387 DOI: 10.1002/mds.26102  0.399
2015 Fahn S, Poewe W. Levodopa: 50 years of a revolutionary drug for Parkinson disease. Movement Disorders : Official Journal of the Movement Disorder Society. 30: 1-3. PMID 25488146 DOI: 10.1002/mds.26122  0.342
2015 Sharp ME, Caccappolo E, Mejia-Santana H, Tang MX, Rosado L, Orbe Reilly M, Ruiz D, Louis ED, Comella C, Nance M, Bressman S, Scott WK, Tanner C, Waters C, Fahn S, et al. The relationship between obsessive-compulsive symptoms and PARKIN genotype: The CORE-PD study. Movement Disorders : Official Journal of the Movement Disorder Society. 30: 278-83. PMID 25393808 DOI: 10.1002/Mds.26065  0.543
2015 Alcalay RN, Mejia-Santana H, Mirelman A, Saunders-Pullman R, Raymond D, Palmese C, Caccappolo E, Ozelius L, Orr-Urtreger A, Clark L, Giladi N, Bressman S, Marder K, Tang MX, Santana HM, ... ... Fahn S, et al. Neuropsychological performance in LRRK2 G2019S carriers with Parkinson's disease Parkinsonism and Related Disorders. 21: 106-110. DOI: 10.1016/j.parkreldis.2014.09.033  0.645
2014 Simon KC, Eberly S, Gao X, Oakes D, Tanner CM, Shoulson I, Fahn S, Schwarzschild MA, Ascherio A. Mendelian randomization of serum urate and parkinson disease progression. Annals of Neurology. 76: 862-8. PMID 25257975 DOI: 10.1002/Ana.24281  0.379
2014 Arkadir D, Bergman H, Fahn S. Redundant dopaminergic activity may enable compensatory axonal sprouting in Parkinson disease. Neurology. 82: 1093-8. PMID 24663231 DOI: 10.1212/WNL.0000000000000243  0.332
2014 Tanner CM, Meng CC, Ravina B, Lang A, Kurlan R, Marek K, Oakes D, Seibyl J, Flagg E, Gauger L, Guest DD, Goetz CG, Kieburtz K, DiEuliis D, Fahn S, et al. A practical approach to remote longitudinal follow-up of Parkinson's disease: the FOUND study. Movement Disorders : Official Journal of the Movement Disorder Society. 29: 743-9. PMID 24515275 DOI: 10.1002/Mds.25814  0.408
2014 Alcalay RN, Caccappolo E, Mejia-Santana H, Tang MX, Rosado L, Orbe Reilly M, Ruiz D, Louis ED, Comella CL, Nance MA, Bressman SB, Scott WK, Tanner CM, Mickel SF, Waters CH, ... Fahn S, et al. Cognitive and motor function in long-duration PARKIN-associated Parkinson disease. Jama Neurology. 71: 62-7. PMID 24190026 DOI: 10.1001/Jamaneurol.2013.4498  0.562
2014 Pahwa R, Lyons KE, Hauser RA, Fahn S, Jankovic J, Pourcher E, Hsu A, O'Connell M, Kell S, Gupta S. Randomized trial of IPX066, carbidopa/levodopa extended release, in early Parkinson's disease. Parkinsonism & Related Disorders. 20: 142-8. PMID 24055014 DOI: 10.1016/j.parkreldis.2013.08.017  0.383
2014 Dinur T, Quinn T, Sakanaka K, Levy O, Marder KS, Waters C, Fahn S, Dorovski T, Pauciulo M, Nichols W, Rana HQ, Balwani M, Bier L, Elstein D, Zimran A, et al. Parkinson disease penetrance in patients with Gaucher disease and in glucocerebrosidase mutation carriers Molecular Genetics and Metabolism. 111: S37-S38. DOI: 10.1016/j.ymgme.2013.12.071  0.495
2013 Alcalay RN, Mirelman A, Saunders-Pullman R, Tang MX, Mejia Santana H, Raymond D, Roos E, Orbe-Reilly M, Gurevich T, Bar Shira A, Gana Weisz M, Yasinovsky K, Zalis M, Thaler A, Deik A, ... ... Fahn S, et al. Parkinson disease phenotype in Ashkenazi Jews with and without LRRK2 G2019S mutations. Movement Disorders : Official Journal of the Movement Disorder Society. 28: 1966-71. PMID 24243757 DOI: 10.1002/Mds.25647  0.703
2013 Mirelman A, Heman T, Yasinovsky K, Thaler A, Gurevich T, Marder K, Bressman S, Bar-Shira A, Orr-Urtreger A, Giladi N, Hausdorff JM, Saunders-Pullman R, Shanker VL, Groves M, Palmese C, ... ... Fahn S, et al. Fall risk and gait in Parkinson's disease: The role of the LRRK2 G2019S mutation Movement Disorders. 28: 1683-1690. PMID 24123150 DOI: 10.1002/Mds.25587  0.676
2013 Liu X, Cheng R, Ye X, Verbitsky M, Kisselev S, Mejia-Santana H, Louis E, Cote L, Andrews H, Waters C, Ford B, Fahn S, Marder K, Lee J, Clark L. Increased Rate of Sporadic and Recurrent Rare Genic Copy Number Variants in Parkinson's Disease Among Ashkenazi Jews. Molecular Genetics & Genomic Medicine. 1: 142-154. PMID 24073418 DOI: 10.1002/Mgg3.18  0.546
2012 Poston KL, Tang CC, Eckert T, Dhawan V, Frucht S, Vonsattel JP, Fahn S, Eidelberg D. Network correlates of disease severity in multiple system atrophy. Neurology. 78: 1237-44. PMID 22491861 DOI: 10.1212/WNL.0b013e318250d7fd  0.385
2012 Alcalay RN, Caccappolo E, Mejia-Santana H, Tang M-, Rosado L, Orbe Reilly M, Ruiz D, Ross B, Verbitsky M, Kisselev S, Louis E, Comella C, Colcher A, Jennings D, Nance M, ... ... Fahn S, et al. Cognitive performance of GBA mutation carriers with early-onset PD: the CORE-PD study. Neurology. 78: 1434-40. PMID 22442429 DOI: 10.1212/Wnl.0B013E318253D54B  0.543
2012 Poulopoulos M, Cortes E, Vonsattel JP, Fahn S, Waters C, Cote LJ, Moskowitz C, Honig LS, Clark LN, Marder KS, Alcalay RN. Clinical and pathological characteristics of LRRK2 G2019S patients with PD. Journal of Molecular Neuroscience : Mn. 47: 139-43. PMID 22194196 DOI: 10.1007/S12031-011-9696-Y  0.568
2012 Lees A, Fahn S, Eggert KM, Jankovic J, Lang A, Micheli F, Mouradian MM, Oertel WH, Olanow CW, Poewe W, Rascol O, Tolosa E, Squillacote D, Kumar D. Perampanel, an AMPA antagonist, found to have no benefit in reducing "off" time in Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 27: 284-8. PMID 22161845 DOI: 10.1002/mds.23983  0.312
2012 Caccappolo E, Alcalay R, Marder K, Tang M, Rosado L, Mejia-Santana H, Ruiz D, Orbe-Reilly M, Ross B, Verbitsky M, Kisselev S, Louis E, Colcher A, Comella C, Siderowf A, ... ... Fahn S, et al. The Effect of Parkin Mutation Status on Cognitive Functioning in EOPD Patients with Long Disease Duration: The CORE-PD Study (PD7.008) Neurology. 78: PD7.008-PD7.008. DOI: 10.1212/wnl.78.1_meetingabstracts.pd7.008  0.495
2012 Alcalay R, Rosado L, Mejia-Santana H, Orbe-Reilly M, Caccappolo E, Tang M, Ruiz D, Ross B, Verbitsky M, Kisselev S, Louis E, Comella C, Colcher A, Jennings D, Nance M, ... ... Fahn S, et al. Clinical and Genetic Characteristics of Participants with Juvenile PD: The CORE-PD Study (IN10-2.001) Neurology. 78: IN10-2.001-IN10-2.00. DOI: 10.1212/Wnl.78.1_Meetingabstracts.In10-2.001  0.537
2011 Srivastava A, Tang MX, Mejia-Santana H, Rosado L, Louis ED, Caccappolo E, Comella C, Colcher A, Siderowf A, Jennings D, Nance M, Bressman S, Scott WK, Tanner C, Mickel S, ... ... Fahn S, et al. The relation between depression and parkin genotype: the CORE-PD study. Parkinsonism & Related Disorders. 17: 740-4. PMID 21856206 DOI: 10.1016/J.Parkreldis.2011.07.008  0.504
2011 Liu X, Cheng R, Verbitsky M, Kisselev S, Browne A, Mejia-Sanatana H, Louis ED, Cote LJ, Andrews H, Waters C, Ford B, Frucht S, Fahn S, Marder K, Clark LN, et al. Genome-wide association study identifies candidate genes for Parkinson's disease in an Ashkenazi Jewish population. Bmc Medical Genetics. 12: 104. PMID 21812969 DOI: 10.1186/1471-2350-12-104  0.519
2011 Alcalay RN, Siderowf A, Ottman R, Caccappolo E, Mejia-Santana H, Tang MX, Rosado L, Louis E, Ruiz D, Waters C, Fahn S, Cote L, Frucht S, Ford B, Orbe-Reilly M, et al. Olfaction in Parkin heterozygotes and compound heterozygotes: the CORE-PD study. Neurology. 76: 319-26. PMID 21205674 DOI: 10.1212/Wnl.0B013E31820882Aa  0.554
2011 Caccappolo E, Alcalay RN, Mejia-Santana H, Tang MX, Rakitin B, Rosado L, Louis ED, Comella CL, Colcher A, Jennings D, Nance MA, Bressman S, Scott WK, Tanner CM, Mickel SF, ... ... Fahn S, et al. Neuropsychological Profile of Parkin Mutation Carriers with and without Parkinson Disease: The CORE-PD Study. Journal of the International Neuropsychological Society : Jins. 17: 91-100. PMID 21092386 DOI: 10.1017/S1355617710001190  0.559
2010 Alcalay RN, Caccappolo E, Mejia-Santana H, Tang MX, Rosado L, Ross BM, Verbitsky M, Kisselev S, Louis ED, Comella C, Colcher A, Jennings D, Nance MA, Bressman SB, Scott WK, ... ... Fahn S, et al. Frequency of known mutations in early-onset Parkinson disease: implication for genetic counseling: the consortium on risk for early onset Parkinson disease study. Archives of Neurology. 67: 1116-22. PMID 20837857 DOI: 10.1001/Archneurol.2010.194  0.575
2010 Gilbert RM, Fahn S, Mitsumoto H, Rowland LP. Parkinsonism and motor neuron diseases: twenty-seven patients with diverse overlap syndromes. Movement Disorders : Official Journal of the Movement Disorder Society. 25: 1868-75. PMID 20669307 DOI: 10.1002/mds.23200  0.634
2010 Marder KS, Tang MX, Mejia-Santana H, Rosado L, Louis ED, Comella CL, Colcher A, Siderowf AD, Jennings D, Nance MA, Bressman S, Scott WK, Tanner CM, Mickel SF, Andrews HF, ... ... Fahn S, et al. Predictors of parkin mutations in early-onset Parkinson disease: the consortium on risk for early-onset Parkinson disease study. Archives of Neurology. 67: 731-8. PMID 20558392 DOI: 10.1001/Archneurol.2010.95  0.554
2010 Fahn S. Parkinson's disease: 10 years of progress, 1997-2007. Movement Disorders : Official Journal of the Movement Disorder Society. 25: S2-14. PMID 20187239 DOI: 10.1002/mds.22796  0.409
2010 Fahn S, Marder K, Côté L. Frontiers of science and clinical advances in quality of life in Parkinson's disease. Preface. Movement Disorders : Official Journal of the Movement Disorder Society. 25: S1. PMID 20187233 DOI: 10.1002/Mds.23029  0.508
2010 Alcalay RN, Mejia-Santana H, Tang MX, Rakitin B, Rosado L, Ross B, Verbitsky M, Kisselev S, Louis ED, Comella CL, Colcher A, Jennings D, Nance MA, Bressman S, Scott WK, ... ... Fahn S, et al. Self-report of cognitive impairment and mini-mental state examination performance in PRKN, LRRK2, and GBA carriers with early onset Parkinson's disease. Journal of Clinical and Experimental Neuropsychology. 32: 775-9. PMID 20182943 DOI: 10.1080/13803390903521018  0.494
2010 Tang CC, Poston KL, Eckert T, Feigin A, Frucht S, Gudesblatt M, Dhawan V, Lesser M, Vonsattel JP, Fahn S, Eidelberg D. Differential diagnosis of parkinsonism: a metabolic imaging study using pattern analysis. The Lancet. Neurology. 9: 149-58. PMID 20061183 DOI: 10.1016/S1474-4422(10)70002-8  0.349
2009 Alcalay RN, Mejia-Santana H, Tang MX, Rosado L, Verbitsky M, Kisselev S, Ross BM, Louis ED, Comella CL, Colcher A, Jennings D, Nance MA, Bressman S, Scott WK, Tanner C, ... ... Fahn S, et al. Motor phenotype of LRRK2 G2019S carriers in early-onset Parkinson disease. Archives of Neurology. 66: 1517-22. PMID 20008657 DOI: 10.1001/Archneurol.2009.267  0.563
2009 Sidransky E, Nalls MA, Aasly JO, Aharon-Peretz J, Annesi G, Barbosa ER, Bar-Shira A, Berg D, Bras J, Brice A, Chen CM, Clark LN, Condroyer C, De Marco EV, Dürr A, ... ... Fahn S, et al. Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease. The New England Journal of Medicine. 361: 1651-61. PMID 19846850 DOI: 10.1056/Nejmoa0901281  0.543
2009 Ascherio A, LeWitt PA, Xu K, Eberly S, Watts A, Matson WR, Marras C, Kieburtz K, Rudolph A, Bogdanov MB, Schwid SR, Tennis M, Tanner CM, Beal MF, Lang AE, ... ... Fahn S, et al. Urate as a predictor of the rate of clinical decline in Parkinson disease. Archives of Neurology. 66: 1460-8. PMID 19822770 DOI: 10.1001/Archneurol.2009.247  0.346
2009 Ravina B, Tanner C, Dieuliis D, Eberly S, Flagg E, Galpern WR, Fahn S, Goetz CG, Grate S, Kurlan R, Lang AE, Marek K, Kieburtz K, Oakes D, Elliott R, et al. A longitudinal program for biomarker development in Parkinson's disease: a feasibility study. Movement Disorders : Official Journal of the Movement Disorder Society. 24: 2081-90. PMID 19691116 DOI: 10.1002/Mds.22690  0.377
2009 Clark LN, Kartsaklis LA, Wolf Gilbert R, Dorado B, Ross BM, Kisselev S, Verbitsky M, Mejia-Santana H, Cote LJ, Andrews H, Vonsattel JP, Fahn S, Mayeux R, Honig LS, Marder K. Association of glucocerebrosidase mutations with dementia with lewy bodies. Archives of Neurology. 66: 578-83. PMID 19433657 DOI: 10.1001/Archneurol.2009.54  0.641
2008 Fahn S. How do you treat motor complications in Parkinson's disease: Medicine, surgery, or both? Annals of Neurology. 64: S56-64. PMID 19127577 DOI: 10.1002/ana.21453  0.331
2008 Goetz CG, Tilley BC, Shaftman SR, Stebbins GT, Fahn S, Martinez-Martin P, Poewe W, Sampaio C, Stern MB, Dodel R, Dubois B, Holloway R, Jankovic J, Kulisevsky J, Lang AE, et al. Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Movement Disorders : Official Journal of the Movement Disorder Society. 23: 2129-70. PMID 19025984 DOI: 10.1002/Mds.22340  0.346
2008 Fahn S. The history of dopamine and levodopa in the treatment of Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 23: S497-508. PMID 18781671 DOI: 10.1002/mds.22028  0.385
2008 Schifitto G, Friedman JH, Oakes D, Shulman L, Comella CL, Marek K, Fahn S. Fatigue in levodopa-naive subjects with Parkinson disease. Neurology. 71: 481-5. PMID 18695158 DOI: 10.1212/01.Wnl.0000324862.29733.69  0.373
2008 Wang Y, Clark LN, Louis ED, Mejia-Santana H, Harris J, Cote LJ, Waters C, Andrews H, Ford B, Frucht S, Fahn S, Ottman R, Rabinowitz D, Marder K. Risk of Parkinson disease in carriers of parkin mutations: estimation using the kin-cohort method. Archives of Neurology. 65: 467-74. PMID 18413468 DOI: 10.1001/Archneur.65.4.467  0.564
2008 Goetz CG, Wuu J, McDermott MP, Adler CH, Fahn S, Freed CR, Hauser RA, Olanow WC, Shoulson I, Tandon PK, Leurgans S. Placebo response in Parkinson's disease: comparisons among 11 trials covering medical and surgical interventions. Movement Disorders : Official Journal of the Movement Disorder Society. 23: 690-9. PMID 18228568 DOI: 10.1002/Mds.21894  0.381
2007 McClelland S, Vonsattel JP, Garcia RE, Amaya MD, Winfield LM, Pullman SL, Yu Q, Fahn S, Ford B, Goodman RR. Relationship of clinical efficacy to postmortem-determined anatomic subthalamic stimulation in Parkinson syndrome. Clinical Neuropathology. 26: 267-75. PMID 18232592 DOI: 10.5414/Npp26267  0.631
2007 Clark LN, Ross BM, Wang Y, Mejia-Santana H, Harris J, Louis ED, Cote LJ, Andrews H, Fahn S, Waters C, Ford B, Frucht S, Ottman R, Marder K. Mutations in the glucocerebrosidase gene are associated with early-onset Parkinson disease. Neurology. 69: 1270-7. PMID 17875915 DOI: 10.1212/01.Wnl.0000276989.17578.02  0.57
2007 Clark LN, Haamer E, Mejia-Santana H, Harris J, Lesage S, Durr A, Bs SJ, Hedrich K, Louis ED, Cote LJ, Andrews H, Fahn S, Waters C, Ford B, Frucht S, et al. Construction and validation of a Parkinson's disease mutation genotyping array for the Parkin gene. Movement Disorders : Official Journal of the Movement Disorder Society. 22: 932-7. PMID 17415800 DOI: 10.1002/Mds.21419  0.565
2007 Lippa CF, Duda JE, Grossman M, Hurtig HI, Aarsland D, Boeve BF, Brooks DJ, Dickson DW, Dubois B, Emre M, Fahn S, Farmer JM, Galasko D, Galvin JE, Goetz CG, et al. DLB and PDD boundary issues: diagnosis, treatment, molecular pathology, and biomarkers. Neurology. 68: 812-9. PMID 17353469 DOI: 10.1212/01.Wnl.0000256715.13907.D3  0.38
2007 Goetz CG, Fahn S, Martinez-Martin P, Poewe W, Sampaio C, Stebbins GT, Stern MB, Tilley BC, Dodel R, Dubois B, Holloway R, Jankovic J, Kulisevsky J, Lang AE, Lees A, et al. Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Process, format, and clinimetric testing plan. Movement Disorders : Official Journal of the Movement Disorder Society. 22: 41-7. PMID 17115387 DOI: 10.1002/mds.21198  0.35
2006 Clark LN, Wang Y, Karlins E, Saito L, Mejia-Santana H, Harris J, Louis ED, Cote LJ, Andrews H, Fahn S, Waters C, Ford B, Frucht S, Ottman R, Marder K. Frequency of LRRK2 mutations in early- and late-onset Parkinson disease. Neurology. 67: 1786-91. PMID 17050822 DOI: 10.1212/01.Wnl.0000244345.49809.36  0.563
2006 Clark LN, Afridi S, Karlins E, Wang Y, Mejia-Santana H, Harris J, Louis ED, Cote LJ, Andrews H, Fahn S, Waters C, Ford B, Frucht S, Ottman R, Marder K. Case-control study of the parkin gene in early-onset Parkinson disease. Archives of Neurology. 63: 548-52. PMID 16606767 DOI: 10.1001/Archneur.63.4.548  0.563
2006 Blindauer K, Shoulson I, Oakes D, Kieburtz K, Schwid S, Fahn S, Stern M, Goetz C, Nutt J, Goren S, Sayag N, Scolnik M, Levy R, Eyal E, Salzman P, et al. A randomized controlled trial of etilevodopa in patients with Parkinson disease who have motor fluctuations. Archives of Neurology. 63: 210-6. PMID 16476809 DOI: 10.1001/Archneur.63.2.210  0.376
2005 Fahn S. Does levodopa slow or hasten the rate of progression of Parkinson's disease? Journal of Neurology. 252: IV37-IV42. PMID 16222436 DOI: 10.1007/s00415-005-4008-5  0.396
2005 Levy G, Louis ED, Cote L, Perez M, Mejia-Santana H, Andrews H, Harris J, Waters C, Ford B, Frucht S, Fahn S, Marder K. Contribution of aging to the severity of different motor signs in Parkinson disease. Archives of Neurology. 62: 467-72. PMID 15767513 DOI: 10.1001/Archneur.62.3.467  0.559
2005 Ravina B, Eidelberg D, Ahlskog JE, Albin RL, Brooks DJ, Carbon M, Dhawan V, Feigin A, Fahn S, Guttman M, Gwinn-Hardy K, McFarland H, Innis R, Katz RG, Kieburtz K, et al. The role of radiotracer imaging in Parkinson disease. Neurology. 64: 208-15. PMID 15668415 DOI: 10.1212/01.Wnl.0000149403.14458.7F  0.33
2005 Clark LN, Nicolai A, Afridi S, Harris J, Mejia-Santana H, Strug L, Cote LJ, Louis ED, Andrews H, Waters C, Ford B, Frucht S, Fahn S, Mayeux R, Ottman R, et al. Pilot association study of the beta-glucocerebrosidase N370S allele and Parkinson's disease in subjects of Jewish ethnicity. Movement Disorders : Official Journal of the Movement Disorder Society. 20: 100-3. PMID 15517591 DOI: 10.1002/Mds.20320  0.69
2004 Fahn S, Sulzer D. Neurodegeneration and neuroprotection in Parkinson disease. Neurorx : the Journal of the American Society For Experimental Neurotherapeutics. 1: 139-54. PMID 15717014 DOI: 10.1602/neurorx.1.1.139  0.397
2004 Fahn S, Oakes D, Shoulson I, Kieburtz K, Rudolph A, Lang A, Olanow CW, Tanner C, Marek K. Levodopa and the progression of Parkinson's disease. The New England Journal of Medicine. 351: 2498-508. PMID 15590952 DOI: 10.1056/Nejmoa033447  0.361
2004 Fahn S. ALS lessons learned from other neurological diseases. Parkinson's disease. Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders : Official Publication of the World Federation of Neurology, Research Group On Motor Neuron Diseases. 5: 26-30. PMID 15512865 DOI: 10.1080/17434470410019852  0.33
2004 Margolis RL, Holmes SE, Rosenblatt A, Gourley L, O'Hearn E, Ross CA, Seltzer WK, Walker RH, Ashizawa T, Rasmussen A, Hayden M, Almqvist EW, Harris J, Fahn S, MacDonald ME, et al. Huntington's Disease-like 2 (HDL2) in North America and Japan. Annals of Neurology. 56: 670-4. PMID 15468075 DOI: 10.1002/Ana.20248  0.349
2004 Ford B, Winfield L, Pullman SL, Frucht SJ, Du Y, Greene P, Cheringal JH, Yu Q, Cote LJ, Fahn S, McKhann GM, Goodman RR. Subthalamic nucleus stimulation in advanced Parkinson's disease: blinded assessments at one year follow up. Journal of Neurology, Neurosurgery, and Psychiatry. 75: 1255-9. PMID 15314110 DOI: 10.1136/jnnp.2003.027557  0.637
2004 Gordon PH, Fahn S, Chin S, Golbe LI, Lynch T, Eidelberg D. Woman with a 26-year history of parkinsonism, supranuclear ophthalmoplegia, and loss of postural reflexes. Movement Disorders : Official Journal of the Movement Disorder Society. 19: 950-61. PMID 15300663 DOI: 10.1002/Mds.20139  0.429
2004 Holloway RG, Shoulson I, Fahn S, Kieburtz K, Lang A, Marek K, McDermott M, Seibyl J, Weiner W, Musch B, Kamp C, Welsh M, Shinaman A, Pahwa R, Barclay L, et al. Pramipexole vs levodopa as initial treatment for Parkinson disease: a 4-year randomized controlled trial. Archives of Neurology. 61: 1044-53. PMID 15262734 DOI: 10.1001/Archneur.61.7.1044  0.377
2004 Levy G, Louis ED, Mejia-Santana H, Côté L, Andrews H, Harris J, Waters C, Ford B, Frucht S, Fahn S, Ottman R, Marder K. Lack of familial aggregation of Parkinson disease and Alzheimer disease. Archives of Neurology. 61: 1033-9. PMID 15262733 DOI: 10.1001/Archneur.61.7.1033  0.556
2004 Clark LN, Afridi S, Mejia-Santana H, Harris J, Louis ED, Cote LJ, Andrews H, Singleton A, Wavrant De-Vrieze F, Hardy J, Mayeux R, Fahn S, Waters C, Ford B, Frucht S, et al. Analysis of an early-onset Parkinson's disease cohort for DJ-1 mutations. Movement Disorders : Official Journal of the Movement Disorder Society. 19: 796-800. PMID 15254937 DOI: 10.1002/Mds.20131  0.675
2004 Gordon PH, Yu Q, Qualls C, Winfield H, Dillon S, Greene PE, Fahn S, Breeze RE, Freed CR, Pullman SL. Reaction time and movement time after embryonic cell implantation in Parkinson disease. Archives of Neurology. 61: 858-61. PMID 15210522 DOI: 10.1001/Archneur.61.6.858  0.638
2004 Munhoz RP, Li JY, Kurtinecz M, Piboolnurak P, Constantino A, Fahn S, Lang AE. Evaluation of the pull test technique in assessing postural instability in Parkinson's disease. Neurology. 62: 125-7. PMID 14718714 DOI: 10.1212/Wnl.62.1.125  0.355
2004 Margolis RL, Holmes SE, Rosenblatt A, Gourley L, O'Hearn E, Ross CA, Seltzer WK, Walker RH, Ashizawa T, Rasmussen A, Hayden M, Almqvist EW, Harris J, Fahn S, MacDonald ME, et al. Erratum: Huntington's disease-like 2 (HDL2) in North America and Japan (Annals of Neurology (November 2004) 56 (670-674)) Annals of Neurology. 56. DOI: 10.1002/Ana.20349  0.324
2003 Rosenberg RN, Pedley TA, Baringer JR, Fahn S, Lisak RP, Mayeux RP, Olson SF, Ringel SP, Rowland LP, Selzer ME. At jeopardy: the NIH as we know it. Neurorehabilitation and Neural Repair. 17: 203-5. PMID 14677215 DOI: 10.1177/0888439003259700  0.71
2003 Louis ED, Levy G, Mejia-Santana H, Cote L, Andrews H, Harris J, Waters C, Ford B, Frucht S, Fahn S, Ottman R, Marder K. Risk of action tremor in relatives of tremor-dominant and postural instability gait disorder PD. Neurology. 61: 931-6. PMID 14557562 DOI: 10.1212/Wnl.61.7.931  0.542
2003 Marder K, Levy G, Louis ED, Mejia-Santana H, Cote L, Andrews H, Harris J, Waters C, Ford B, Frucht S, Fahn S, Ottman R. Familial aggregation of early- and late-onset Parkinson's disease. Annals of Neurology. 54: 507-13. PMID 14520664 DOI: 10.1002/Ana.10711  0.541
2003 Rosenberg RN, Pedley TA, Baringer JR, Fahn S, Lisak RP, Mayeux RP, Olson SF, Ringel SP, Rowland LP, Selzer ME. At jeopardy: the NIH as we know it. Archives of Neurology. 60: 1191-2. PMID 12975281 DOI: 10.1001/archneur.60.9.1191  0.71
2003 Marder K, Levy G, Louis ED, Mejia-Santana H, Cote L, Andrews H, Harris J, Waters C, Ford B, Frucht S, Fahn S, Ottman R. Accuracy of family history data on Parkinson's disease. Neurology. 61: 18-23. PMID 12847150 DOI: 10.1212/01.Wnl.0000074784.35961.C0  0.537
2003 Trott CT, Fahn S, Greene P, Dillon S, Winfield H, Winfield L, Kao R, Eidelberg D, Freed CR, Breeze RE, Stern Y. Cognition following bilateral implants of embryonic dopamine neurons in PD: a double blind study. Neurology. 60: 1938-43. PMID 12821736 DOI: 10.1212/01.Wnl.0000070181.28651.3B  0.472
2002 Greene PE, Fahn S. Status of fetal tissue transplantation for the treatment of advanced Parkinson disease. Neurosurgical Focus. 13: e3. PMID 15769072 DOI: 10.3171/Foc.2002.13.5.4  0.357
2002 Gordon PH, Pullman SL, Louis ED, Frucht SJ, Fahn S. Mirtazapine in Parkinsonian tremor. Parkinsonism & Related Disorders. 9: 125-6. PMID 12473405 DOI: 10.1016/S1353-8020(02)00011-1  0.628
2002 Siderowf A, Stern M, Shoulson I, Kieburtz K, Oakes D, Day D, Shinaman A, Plumb S, Fahn S, Blindauer K, Lew M, Hurtig H, Lloyd M, Hauser R, Gauger L, et al. A controlled trial of rasagiline in early Parkinson disease: The tempo study Archives of Neurology. 59: 1937-1943. PMID 12470183 DOI: 10.1001/Archneur.59.12.1937  0.38
2002 Kock N, Müller B, Vieregge P, Pramstaller PP, Marder K, Abbruzzese G, Martinelli P, Lang AE, Jacobs H, Hagenah J, Harris J, Meija-Santana H, Fahn S, Hedrich K, Kann M, et al. Role of SCA2 mutations in early- and late-onset dopa-responsive parkinsonism. Annals of Neurology. 52: 257-8; author reply . PMID 12210804 DOI: 10.1002/Ana.10270  0.514
2002 Louis ED, Levy G, Côte LJ, Mejia H, Fahn S, Marder K. Diagnosing Parkinson's disease using videotaped neurological examinations: validity and factors that contribute to incorrect diagnoses. Movement Disorders : Official Journal of the Movement Disorder Society. 17: 513-7. PMID 12112199 DOI: 10.1002/Mds.10119  0.575
2002 Hedrich K, Marder K, Harris J, Kann M, Lynch T, Meija-Santana H, Pramstaller PP, Schwinger E, Bressman SB, Fahn S, Klein C. Evaluation of 50 probands with early-onset Parkinson's disease for Parkin mutations. Neurology. 58: 1239-46. PMID 11971093 DOI: 10.1212/Wnl.58.8.1239  0.623
2002 Pedley TA, Swift TR, Miller A, Fahn S. Pharmaceutical industry support of the AAN Annual Meeting: policies and violation. Neurology. 58: 519-21. PMID 11865126 DOI: 10.1212/Wnl.58.4.519  0.612
2001 Lynch T, Sano M, Marder KS, Bell KL, Foster NL, Defendini RF, Sima AA, Keohane C, Nygaard TG, Fahn S, Mayeux R, Rowland LP, Wilhelmsen KC. Clinical characteristics of a family with chromosome 17-linked disinhibition-dementia-parkinsonism-amyotrophy complex. 1994. Neurology. 57: S39-45. PMID 11775599  0.718
2001 Louis ED, Levy G, Côte LJ, Mejia H, Fahn S, Marder K. Clinical correlates of action tremor in Parkinson disease. Archives of Neurology. 58: 1630-4. PMID 11594921 DOI: 10.1001/Archneur.58.10.1630  0.58
2001 Nakamura T, Dhawan V, Chaly T, Fukuda M, Ma Y, Breeze R, Greene P, Fahn S, Freed C, Eidelberg D. Blinded positron emission tomography study of dopamine cell implantation for Parkinson's disease. Annals of Neurology. 50: 181-7. PMID 11506400 DOI: 10.1002/Ana.1075  0.343
2001 Giladi N, McDermott MP, Fahn S, Przedborski S, Jankovic J, Stern M, Tanner C. Freezing of gait in PD: prospective assessment in the DATATOP cohort. Neurology. 56: 1712-21. PMID 11425939 DOI: 10.1212/Wnl.56.12.1712  0.343
2001 Louis ED, Winfield L, Fahn S, Ford B. Speech dysfluency exacerbated by levodopa in Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 16: 562-5. PMID 11391759 DOI: 10.1002/Mds.1081  0.393
2001 Freed CR, Greene PE, Breeze RE, Tsai WY, DuMouchel W, Kao R, Dillon S, Winfield H, Culver S, Trojanowski JQ, Eidelberg D, Fahn S. Transplantation of embryonic dopamine neurons for severe Parkinson's disease. The New England Journal of Medicine. 344: 710-9. PMID 11236774 DOI: 10.1056/Nejm200103083441002  0.332
2000 Thyagarajan D, Bressman S, Bruno C, Przedborski S, Shanske S, Lynch T, Fahn S, DiMauro S. A novel mitochondrial 12SrRNA point mutation in parkinsonism, deafness, and neuropathy. Annals of Neurology. 48: 730-6. PMID 11079536 DOI: 10.1002/1531-8249(200011)48:5<730::AID-ANA6>3.0.CO;2-0  0.402
2000 Bressman SB, Sabatti C, Raymond D, de Leon D, Klein C, Kramer PL, Brin MF, Fahn S, Breakefield X, Ozelius LJ, Risch NJ. The DYT1 phenotype and guidelines for diagnostic testing. Neurology. 54: 1746-52. PMID 10802779 DOI: 10.1212/Wnl.54.9.1746  0.306
2000 Furukawa Y, Hornykiewicz O, Fahn S, Kish SJ. Striatal dopamine in early-onset primary torsion dystonia with the DYT1 mutation. Neurology. 54: 1193-5. PMID 10720299 DOI: 10.1212/Wnl.54.5.1193  0.337
1999 Agid Y, Ahlskog E, Albanese A, Calne D, Chase T, De Yebenes J, Factor S, Fahn S, Gershanik O, Goetz C, Koller W, Kurth M, Lang A, Lees A, Lewitt P, et al. Levodopa in the treatment of Parkinson's disease: a consensus meeting. Movement Disorders : Official Journal of the Movement Disorder Society. 14: 911-3. PMID 10584663 DOI: 10.1002/1531-8257(199911)14:6<911::Aid-Mds1001>3.0.Co;2-H  0.383
1999 Frucht S, Rogers JD, Greene PE, Gordon MF, Fahn S. Falling asleep at the wheel: motor vehicle mishaps in persons taking pramipexole and ropinirole. Neurology. 52: 1908-10. PMID 10371546 DOI: 10.1212/Wnl.52.9.1908  0.329
1999 Fahn S. Parkinson disease, the effect of levodopa, and the ELLDOPA trial. Earlier vs Later L-DOPA. Archives of Neurology. 56: 529-35. PMID 10328247 DOI: 10.1001/Archneur.56.5.529  0.406
1999 Saunders-Pullman R, Gordon-Elliott J, Parides M, Fahn S, Saunders HR, Bressman S. The effect of estrogen replacement on early Parkinson's disease. Neurology. 52: 1417-21. PMID 10227628 DOI: 10.1212/Wnl.52.7.1417  0.367
1998 Lieberman A, Olanow CW, Sethi K, Swanson P, Waters CH, Fahn S, Hurtig H, Yahr M. A multicenter trial of ropinirole as adjunct treatment for Parkinson's disease. Ropinirole Study Group. Neurology. 51: 1057-62. PMID 9781529 DOI: 10.1212/WNL.51.4.1057  0.378
1998 Fahn S, Clarence-Smith KE, Chase TN. Parkinson's disease: neurodegenerative mechanisms and neuroprotective interventions--report of a workshop. Movement Disorders : Official Journal of the Movement Disorder Society. 13: 759-67. PMID 9756143 DOI: 10.1002/Mds.870130502  0.344
1998 Hutton M, Lendon CL, Rizzu P, Baker M, Froelich S, Houlden H, Pickering-Brown S, Chakraverty S, Isaacs A, Grover A, Hackett J, Adamson J, Lincoln S, Dickson D, Davies P, ... ... Fahn S, et al. Association of missense and 5'-splice-site mutations in tau with the inherited dementia FTDP-17. Nature. 393: 702-5. PMID 9641683 DOI: 10.1038/31508  0.503
1998 Fahn S. Tolcapone: COMT inhibition for the treatment of Parkinson's disease. Neurology. 50: S1-2. PMID 9591515 DOI: 10.1212/Wnl.50.5_Suppl_5.S1  0.4
1998 Dauer WT, Burke RE, Greene P, Fahn S. Current concepts on the clinical features, aetiology and management of idiopathic cervical dystonia. Brain : a Journal of Neurology. 121: 547-60. PMID 9577384 DOI: 10.1093/brain/121.4.547  0.332
1997 Chouinard S, Louis ED, Fahn S. Agreement among movement disorder specialists on the clinical diagnosis of essential tremor. Movement Disorders : Official Journal of the Movement Disorder Society. 12: 973-6. PMID 9399223 DOI: 10.1002/Mds.870120621  0.305
1997 Lynch T, Fahn S, Louis ED, Odel JG. Oculofacial-skeletal myorhythmia in Whipple's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 12: 625-6. PMID 9251096  0.459
1997 Lynch T, Odel J, Fredericks DN, Louis ED, Forman S, Rotterdam H, Fahn S, Relman DA. Polymerase chain reaction-based detection of Tropheryma whippelii in central nervous system Whipple's disease. Annals of Neurology. 42: 120-4. PMID 9225695 DOI: 10.1002/Ana.410420120  0.513
1997 Bressman SB, de Leon D, Raymond D, Greene PE, Brin MF, Fahn S, Ozelius LJ, Breakefield XO, Kramer PL, Risch NJ. Secondary dystonia and the DYTI gene. Neurology. 48: 1571-7. PMID 9191768 DOI: 10.1212/WNL.48.6.1571  0.304
1997 Louis ED, Ottman R, Ford B, Pullman S, Martinez M, Fahn S, Hauser WA. The Washington Heights-Inwood Genetic Study of Essential Tremor: methodologic issues in essential-tremor research. Neuroepidemiology. 16: 124-33. PMID 9159767 DOI: 10.1159/000109681  0.519
1997 Fahn S. An overview of novel therapies for Parkinson's disease. Experimental Neurology. 144: 21-3. PMID 9126146 DOI: 10.1006/exnr.1996.6382  0.355
1997 Louis ED, Klatka LA, Liu Y, Fahn S. Comparison of extrapyramidal features in 31 pathologically confirmed cases of diffuse Lewy body disease and 34 pathologically confirmed cases of Parkinson's disease. Neurology. 48: 376-80. PMID 9040725 DOI: 10.1212/Wnl.48.2.376  0.397
1996 Olanow CW, Fahn S, Langston JW, Godbold J. Selegiline and mortality in Parkinson's disease. Annals of Neurology. 40: 841-5. PMID 9007088 DOI: 10.1002/ana.410400605  0.336
1996 Ford B, Greene P, Louis ED, Petzinger G, Bressman SB, Goodman R, Brin MF, Sadiq S, Fahn S. Use of intrathecal baclofen in the treatment of patients with dystonia. Archives of Neurology. 53: 1241-6. PMID 8970452 DOI: 10.1001/Archneur.1996.00550120049016  0.301
1996 Fahn S. Is levodopa toxic? Neurology. 47: S184-95. PMID 8959987 DOI: 10.1212/Wnl.47.6_Suppl_3.184S  0.39
1996 Pullman SL, Greene P, Fahn S, Pedersen SF. Approach to the treatment of limb disorders with botulinum toxin A. Experience with 187 patients. Archives of Neurology. 53: 617-24. PMID 8929169 DOI: 10.1001/Archneur.1996.00550070055012  0.59
1996 Louis ED, Lynch T, Kaufmann P, Fahn S, Odel J. Diagnostic guidelines in central nervous system Whipple's disease. Annals of Neurology. 40: 561-8. PMID 8871574 DOI: 10.1002/Ana.410400404  0.535
1996 Tan A, Salgado M, Fahn S. Rapid eye movement sleep behavior disorder preceding Parkinson's disease with therapeutic response to levodopa. Movement Disorders : Official Journal of the Movement Disorder Society. 11: 214-6. PMID 8684394 DOI: 10.1002/mds.870110216  0.369
1996 Louis ED, Lynch T, Marder K, Fahn S. Reliability of patient completion of the historical section of the Unified Parkinson's Disease Rating Scale. Movement Disorders : Official Journal of the Movement Disorder Society. 11: 185-92. PMID 8684390 DOI: 10.1002/Mds.870110212  0.61
1996 Louis ED, Lynch T, Ford B, Greene P, Bressman SB, Fahn S. Delayed-onset cerebellar syndrome. Archives of Neurology. 53: 450-4. PMID 8624221 DOI: 10.1001/Archneur.1996.00550050080027  0.519
1996 Pullman SL, Ford B, Elibol B, Uncini A, Su PC, Fahn S. Cutaneous electromyographic silent period findings in brachial dystonia. Neurology. 46: 503-8. PMID 8614522 DOI: 10.1212/Wnl.46.2.503  0.652
1996 Fahn S. Book Review The Case of the Frozen Addicts: How the solution of an extraordinary medical mystery spawned a revolution in the understanding and treatment of Parkinson's disease By J. William Langston and Jon Palfreman. 309 pp. New York, Pantheon, 1996. $25. 0-679-42465-2 The New England Journal of Medicine. 335: 2002-2003. DOI: 10.1056/Nejm199612263352618  0.317
1995 Ford B, Fahn S, Pullman SL. Peripherally induced EMG silent periods. Normal physiology and disorders of motor control. Advances in Neurology. 67: 321-8. PMID 8848978  0.556
1995 Louis ED, Lynch T, Cargan AL, Fahn S. Generalized chorea in an infant with semilobar holoprosencephaly. Pediatric Neurology. 13: 355-7. PMID 8771177 DOI: 10.1016/0887-8994(95)00221-9  0.487
1995 Stewart C, Winfield L, Hunt A, Bressman SB, Fahn S, Blitzer A, Brin MF. Speech dysfunction in early Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 10: 562-5. PMID 8552106 DOI: 10.1002/mds.870100506  0.37
1995 McDermott MP, Jankovic J, Carter J, Fahn S, Gauthier S, Goetz CG, Golbe LI, Koller W, Lang AE, Olanow CW. Factors predictive of the need for levodopa therapy in early, untreated Parkinson's disease. The Parkinson Study Group. Archives of Neurology. 52: 565-70. PMID 7763203 DOI: 10.1001/Archneur.1995.00540300037010  0.395
1995 Louis ED, Goldman JE, Powers JM, Fahn S. Parkinsonian features of eight pathologically diagnosed cases of diffuse Lewy body disease. Movement Disorders : Official Journal of the Movement Disorder Society. 10: 188-94. PMID 7753061 DOI: 10.1002/Mds.870100209  0.399
1995 Przedborski S, Jackson-Lewis V, Fahn S. Antiparkinsonian therapies and brain mitochondrial complex I activity. Movement Disorders : Official Journal of the Movement Disorder Society. 10: 312-7. PMID 7651449 DOI: 10.1002/Mds.870100314  0.324
1995 Goetz CG, Stebbins GT, Chmura TA, Fahn S, Klawans HL, Marsden CD. Teaching tape for the motor section of the unified Parkinson's disease rating scale. Movement Disorders : Official Journal of the Movement Disorder Society. 10: 263-6. PMID 7544438 DOI: 10.1002/mds.870100305  0.306
1994 Lynch T, Burke RE, Fahn S. Progress in psychiatry. The New England Journal of Medicine. 330: 285-6. PMID 8272093  0.397
1994 Olanow CW, Fahn S, Muenter M, Klawans H, Hurtig H, Stern M, Shoulson I, Kurlan R, Grimes JD, Jankovic J. A multicenter double-blind placebo-controlled trial of pergolide as an adjunct to Sinemet in Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 9: 40-7. PMID 8139604 DOI: 10.1002/Mds.870090107  0.361
1994 Przedborski S, Giladi N, Takikawa S, Ishikawa T, Dhawan V, Spetsieris P, Chaly T, Fahn S, Eidelberg D. Metabolic topography of the hemiparkinsonism-hemiatrophy syndrome. Neurology. 44: 1622-8. PMID 7936286 DOI: 10.1212/Wnl.44.9.1622  0.312
1994 Fahn S, Mayeux R, Rowland LP. A new eponym: Wilhelmsen-Lynch disease. Neurology. 44: 1980. PMID 7936262 DOI: 10.1212/WNL.44.10.1980  0.692
1994 Lynch T, Sano M, Marder KS, Bell KL, Foster NL, Defendini RF, Sima AA, Keohane C, Nygaard TG, Fahn S. Clinical characteristics of a family with chromosome 17-linked disinhibition-dementia-parkinsonism-amyotrophy complex. Neurology. 44: 1878-84. PMID 7936241 DOI: 10.1212/Wnl.44.10.1878  0.627
1994 Pullman SL, Elibol B, Fahn S. Modulation of parkinsonian tremor by radial nerve palsy. Neurology. 44: 1861-4. PMID 7936237 DOI: 10.1212/Wnl.44.10.1861  0.623
1993 Dwork AJ, Balmaceda C, Fazzini EA, MacCollin M, Côté L, Fahn S. Dominantly inherited, early-onset parkinsonism: neuropathology of a new form. Neurology. 43: 69-74. PMID 8423914 DOI: 10.1212/WNL.43.1_Part_1.69  0.349
1993 Przedborski S, Jackson-Lewis V, Muthane U, Jiang H, Ferreira M, Naini AB, Fahn S. Chronic levodopa administration alters cerebral mitochondrial respiratory chain activity. Annals of Neurology. 34: 715-23. PMID 8239566 DOI: 10.1002/Ana.410340515  0.354
1992 Giladi N, McMahon D, Przedborski S, Flaster E, Guillory S, Kostic V, Fahn S. Motor blocks in Parkinson's disease. Neurology. 42: 333-9. PMID 1736161 DOI: 10.1212/Wnl.42.2.333  0.412
1992 Fahn S. Fetal-tissue transplants in Parkinson's disease. The New England Journal of Medicine. 327: 1589-90. PMID 1435887 DOI: 10.1056/NEJM199211263272209  0.308
1992 Gasser T, Fahn S, Breakefield XO. The autosomal dominant dystonias. Brain Pathology (Zurich, Switzerland). 2: 297-308. PMID 1341964 DOI: 10.1111/J.1750-3639.1992.Tb00707.X  0.309
1991 Chan J, Brin MF, Fahn S. Idiopathic cervical dystonia: clinical characteristics. Movement Disorders : Official Journal of the Movement Disorder Society. 6: 119-26. PMID 2057004 DOI: 10.1002/mds.870060206  0.308
1991 Saint Hilaire MH, Burke RE, Bressman SB, Brin MF, Fahn S. Delayed-onset dystonia due to perinatal or early childhood asphyxia. Neurology. 41: 216-22. PMID 1992364 DOI: 10.1212/Wnl.41.2_Part_1.216  0.319
1991 Nygaard TG, Marsden CD, Fahn S. Dopa-responsive dystonia: long-term treatment response and prognosis. Neurology. 41: 174-81. PMID 1899474 DOI: 10.1212/WNL.41.2_Part_1.174  0.344
1991 Przedborski S, Levivier M, Kostic V, Jackson-Lewis V, Dollison A, Gash DM, Fahn S, Cadet JL. Sham transplantation protects against 6-hydroxydopamine-induced dopaminergic toxicity in rats: behavioral and morphological evidence. Brain Research. 550: 231-8. PMID 1832076 DOI: 10.1016/0006-8993(91)91323-S  0.346
1991 Eidelberg D, Dhawan V, Moeller JR, Sidtis JJ, Ginos JZ, Strother SC, Cederbaum J, Greene P, Fahn S, Powers JM. The metabolic landscape of cortico-basal ganglionic degeneration: regional asymmetries studied with positron emission tomography. Journal of Neurology, Neurosurgery, and Psychiatry. 54: 856-62. PMID 1744638 DOI: 10.1136/jnnp.54.10.856  0.32
1990 Nygaard TG, Trugman JM, de Yebenes JG, Fahn S. Dopa-responsive dystonia: the spectrum of clinical manifestations in a large North American family. Neurology. 40: 66-9. PMID 2296384 DOI: 10.1212/WNL.40.1.66  0.314
1990 Fahn S, Burke R, Stern Y. Antimuscarinic drugs in the treatment of movement disorders. Progress in Brain Research. 84: 389-97. PMID 2267310 DOI: 10.1016/S0079-6123(08)60922-X  0.419
1990 Giladi N, Burke RE, Kostic V, Przedborski S, Gordon M, Hunt A, Fahn S. Hemiparkinsonism-hemiatrophy syndrome: clinical and neuroradiologic features. Neurology. 40: 1731-4. PMID 2234429 DOI: 10.1212/Wnl.40.11.1731  0.32
1990 Eidelberg D, Moeller JR, Dhawan V, Sidtis JJ, Ginos JZ, Strother SC, Cedarbaum J, Greene P, Fahn S, Rottenberg DA. The metabolic anatomy of Parkinson's disease: complementary [18F]fluorodeoxyglucose and [18F]fluorodopa positron emission tomographic studies. Movement Disorders : Official Journal of the Movement Disorder Society. 5: 203-13. PMID 2117706 DOI: 10.1002/mds.870050304  0.329
1989 Blitzer A, Brin MF, Greene PE, Fahn S. Botulinum toxin injection for the treatment of oromandibular dystonia. The Annals of Otology, Rhinology, and Laryngology. 98: 93-7. PMID 2916831 DOI: 10.1177/000348948909800202  0.31
1989 Fahn S. Clinical variants of idiopathic torsion dystonia. Journal of Neurology, Neurosurgery, and Psychiatry. 96-100. PMID 2666583 DOI: 10.1136/jnnp.52.Suppl.96  0.308
1989 Fahn S. The history of parkinsonism. Movement Disorders : Official Journal of the Movement Disorder Society. S2-10. PMID 2657407 DOI: 10.1002/MDS.870040502  0.394
1989 Burke RE, Kang UJ, Jankovic J, Miller LG, Fahn S. Tardive akathisia: an analysis of clinical features and response to open therapeutic trials. Movement Disorders : Official Journal of the Movement Disorder Society. 4: 157-75. PMID 2567492 DOI: 10.1002/Mds.870040208  0.329
1989 Kang UJ, Fahn S, Schwarz H, Shoulson I, Vallejos H, Goldman J. Case 1, 1989: juvenile-onset parkinsonism, dystonia, and pyramidal tract signs. Movement Disorders : Official Journal of the Movement Disorder Society. 4: 363-70. PMID 2530440 DOI: 10.1002/Mds.870040414  0.335
1988 Blitzer A, Brin MF, Fahn S, Lovelace RE. Clinical and laboratory characteristics of focal laryngeal dystonia: study of 110 cases. The Laryngoscope. 98: 636-40. PMID 3374239 DOI: 10.1288/00005537-198806000-00012  0.317
1988 Mayeux R, Stern Y, Rosenstein R, Marder K, Hauser A, Cote L, Fahn S. An estimate of the prevalence of dementia in idiopathic Parkinson's disease. Archives of Neurology. 45: 260-2. PMID 3341950 DOI: 10.1001/Archneur.1988.00520270034017  0.715
1988 de Yebenes JG, Brin MF, Mena MA, De Felipe C, del Rio RM, Bazan E, Martinez A, Fahn S, Del Rio J, Vazquez A. Neurochemical findings in neuroacanthocytosis. Movement Disorders : Official Journal of the Movement Disorder Society. 3: 300-12. PMID 2905427 DOI: 10.1002/mds.870030404  0.319
1988 Shoulson I, Fahn S, Langston JW. Symposium on the Etiology, Pathogenesis, and Prevention of Parkinson's Disease Archives of Neurology. 45: 807-811. DOI: 10.1001/ARCHNEUR.1988.00520310125030  0.385
1986 Burke RE, Brin MF, Fahn S, Bressman SB, Moskowitz C. Analysis of the clinical course of non-Jewish, autosomal dominant torsion dystonia. Movement Disorders : Official Journal of the Movement Disorder Society. 1: 163-78. PMID 3504242 DOI: 10.1002/mds.870010302  0.312
1986 Shale H, Fahn S, Mayeux R. Tics in a patient with Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 1: 79-83. PMID 3504234 DOI: 10.1002/mds.870010111  0.615
1986 Hassan MN, Higgins D, Traub M, Fahn S. Chronic treatment with bromocriptine induces behavioral supersensitivity in rats Life Sciences. 39: 513-518. PMID 3090394 DOI: 10.1016/0024-3205(86)90507-2  0.3
1986 Mayeux R, Stern Y, Herman A, Greenbaum L, Fahn S. Correlates of early disability in Huntington's disease. Annals of Neurology. 20: 727-31. PMID 2949692 DOI: 10.1002/Ana.410200613  0.625
1985 Fahn S. Wilson's Disease Neurology. 35: 624-624. DOI: 10.1212/WNL.35.4.624  0.328
1984 Fahn S, Bressman SB. Should levodopa therapy for Parkinsonism be started early or late? Evidence against early treatment. The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques. 11: 200-5. PMID 6713318 DOI: 10.1017/S0317167100046412  0.317
1984 Stern Y, Mayeux R, Ilson J, Fahn S, Cote L. Pergolide therapy for Parkinson's disease: neurobehavioral changes. Neurology. 34: 201-4. PMID 6538009 DOI: 10.1212/Wnl.34.2.201  0.641
1984 Reches A, Wagner HR, Barkai AI, Jackson V, Yablonskaya-Alter E, Fahn S. Electroconvulsive treatment and haloperidol: effects on pre- and postsynaptic dopamine receptors in rat brain. Psychopharmacology. 83: 155-8. PMID 6431465 DOI: 10.1007/BF00429725  0.302
1984 Fahn S. Parkinson-Specific Motor and Mental Disorders-Role of the Pallidum: Pathophysiological, Biochemical, and Therapeutic Aspects (Advances in Neurology, Vol. 40) Neurology. 34: 846-846. DOI: 10.1212/WNL.34.6.846  0.304
1984 Fahn S. Alzheimer's Disease: A Report of Progress in Research Neurology. 34: 138-138. DOI: 10.1212/WNL.34.1.138-a  0.314
1983 Ilson J, Fahn S, Mayeux R, Cote LJ, Snider SR. Pergolide treatment in parkinsonism. Advances in Neurology. 37: 85-94. PMID 6858780  0.509
1983 Jiang D, Reches A, Fahn S. Normal erythrocyte uptake of L-DOPA in Parkinson's, Huntington's, and related diseases. Neurology. 33: 793-6. PMID 6221201 DOI: 10.1212/WNL.33.6.793  0.346
1982 Matison R, Mayeux R, Rosen J, Fahn S. "Tip-of-the-tongue" phenomenon in Parkinson disease. Neurology. 32: 567-70. PMID 7200216 DOI: 10.1212/WNL.32.5.567  0.592
1982 Mayeux R, Fahn S. Paroxysmal dystonic choreoathetosis in a patient with familial ataxia. Neurology. 32: 1184-6. PMID 6889704 DOI: 10.1212/Wnl.32.10.1184  0.535
1982 Burke RE, Fahn S, Jankovic J, Marsden CD, Lang AE, Gollomp S, Ilson J. Tardive dystonia: late-onset and persistent dystonia caused by antipsychotic drugs. Neurology. 32: 1335-46. PMID 6128697 DOI: 10.1212/WNL.32.12.1335  0.312
1981 Burke RE, Fahn S, Mayeux R, Weinberg H, Louis K, Willner JH. Neuroleptic malignant syndrome caused by dopamine-depleting drugs in a patient with Huntington disease. Neurology. 31: 1022-5. PMID 6115336 DOI: 10.1212/Wnl.31.8.1022  0.556
1980 Mayeux R, Hunter S, Fahn S. More on myoclonus in Alzheimer disease. Annals of Neurology. 8: 200. PMID 7425576 DOI: 10.1002/ana.410080214  0.552
1980 Fahn S, Mayeux R. Unilateral Parkinson's disease and contralateral tardive dyskinesia: a unique case with successful therapy that may explain the pathophysiology of these two disorders. Journal of Neural Transmission. Supplementum. 179-85. PMID 6933220  0.564
1980 Fahn S. Huntington's Disease. Advances in Neurology, Vol. 23 Neurology. 30: 793-793. DOI: 10.1212/WNL.30.7.793-a  0.344
1979 Lesser RP, Fahn S, Snider SR, Cote LJ, Isgreen WP, Barrett RE. Analysis of the clinical problems in parkinsonism and the complications of long-term levodopa therapy. Neurology. 29: 1253-60. PMID 573405 DOI: 10.1212/WNL.29.9_Part_1.1253  0.338
1979 Fahn S, Cote LJ, Snider SR, Barrett RE, Isgreen WP. The role of bromocriptine in the treatment of parkinsonism. Neurology. 29: 1077-83. PMID 572493 DOI: 10.1212/WNL.29.8.1077  0.306
1979 FAHN S. Parkinson's Disease: A Guide for Patient and Family Neurology. 29: 532-532. DOI: 10.1212/WNL.29.4.532-B  0.378
1979 MAYEUX R, FAHN S. Cerebral arteritis associated with ulcerative colitis Neurology. 29: 425-425. DOI: 10.1212/WNL.29.3.425-a  0.491
1978 Mayeux R, Fahn S. Strokes and ulcerative colitis. Neurology. 28: 571-4. PMID 565888 DOI: 10.1212/Wnl.28.6.571  0.53
1978 FAHN S, CALNE DB. Need for uncombined carbidopa to treat parkinsonism Neurology. 28: 1070-1070. DOI: 10.1212/WNL.28.10.1070  0.371
1976 Snider SR, Fahn S, Isgreen WP, Cote LJ. Primary sensory symptoms in parkinsonism. Neurology. 26: 423-9. PMID 944393 DOI: 10.1212/WNL.26.5.423  0.313
1975 Fahn S, Isgreen WP. Long-term evaluation of amantadine and levodopa combination in parkinsonism by double-blind corssover analyses. Neurology. 25: 695-700. PMID 807869 DOI: 10.1212/WNL.25.8.695  0.339
1974 Earnest MP, Fahn S, Karp JH, Rowland LP. Normal pressure hydrocephalus and hypertensive cerebrovascular disease. Archives of Neurology. 31: 262-6. PMID 4414845 DOI: 10.1001/Archneur.1974.00490400076009  0.608
1973 Brait K, Fahn S, Schwarz GA. Sporadic and familial parkinsonism and motor neuron disease. Neurology. 23: 990-1002. PMID 4737691 DOI: 10.1212/WNL.23.9.990  0.327
1964 ROWLAND LP, FAHN S, HIRSCHBERG E, HARTER DH. MYOGLOBINURIA. Archives of Neurology. 10: 537-62. PMID 14130414  0.503
1963 FAHN S, SCHOTLAND DL, ROWLAND LP. MCARDLE'S DISEASE: HEREDITARY MYOPATHY DUE TO ABSENCE OF MUSCLE PHOSPHORYLASE. Transactions of the American Neurological Association. 88: 145-7. PMID 14272202  0.564
1963 ROWLAND LP, FAHN S, SCHOTLAND DL. MCARDLE'S DISEASE. HEREDITARY MYOPATHY DUE TO ABSENCE OF MUSCLE PHOSPHORYLASE. Archives of Neurology. 9: 325-42. PMID 14055781 DOI: 10.1001/archneur.1963.00460100013001  0.613
Show low-probability matches.